GLP-1 profile leaves Novo Nordisk after 36 years

Lotte Bjerre Knudsen, one of the key figures behind Novo Nordisk’s success in obesity medicines, is leaving the company after more than three decades.

Swedish industrial group Alfa Laval establishes pharmaceutical division

Alfa Laval is creating a new division focused on tailored solutions for the pharmaceutical industry.

Dive Into Current Metrology Trends

ZEISS INNOVATION TALKS - new video podcast series.

New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows

Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.

Automated high-speed scanning of probes

ZEISS Axioscan 7 spatial biology.

Unlocking the future of medtech

Navigating the European medtech regulatory jungle? Good news —real progress is ahead.

New global standard for clinical evaluation is on the horizon: ISO/DIS 18969

A new global standard for clinical evaluation is on the horizon: ISO/DIS 18969. The core message is straightforward: clinical evaluations should be seen as a pr...

Internal audits based on ISO 13485 for medtech organizations

Are you ready to turn your internal audits into real improvements? Internal auditing isn’t just about compliance—it’s a strategic tool for driving development a...

Long-Term Volumetric Imaging of Living Cells

ZEISS Lattice Lightsheet 7.

Mercodia AB

GSK eyes blockbuster potential – plans five new trials

GSK sees blockbuster potential in its experimental drug candidate Mo-rez. Early trial results suggest the treatment may shrink tumours in patients with advanced...

Quality management system according to EN ISO 13485:2016 – in practice

Do you work with medical devices? Understanding and implementing a robust Quality Management System (QMS) is key to regulatory success—and often a prerequisite for CE-marking.

How MoniDose strengthened their regulatory confidence—fast

When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.

Sprint Bioscience builds the molecules that will become new medicines

In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...

First injectable cancer medicine for home use receives green light

Johnson & Johnson has announced that its blockbuster cancer medicine Darzalex (daratumumab) is set to become the first injectable cancer treatment in Europe sui...

Nordic collaboration delivering the next leap in spatial biology

Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...

Drug approved for condition causing extreme hunger

The U.S. Food and Drug Administration (FDA) has for the first time approved a drug for acquired hypothalamic obesity, a condition marked by rapid weight gain dr...

Disappointment for Diamyd in Phase III – the share price plunges

Diamyd Medical’s share was sharply down on Monday following negative Phase III results. “This outcome is highly unexpected,” said the company’s CEO, Ulf Hannelius.

Lundbeck appoints Chief AI Officer

Danish pharmaceutical company Lundbeck has appointed Markus Kede as Chief AI Officer. He will join the Executive Leadership Team and report to President and CEO Charl van Zyl.

“Ozempic babies” – myth or reality?

Have weight-loss drugs such as Ozempic led to a rise in unplanned pregnancies? Life Science Sweden takes a closer look.

Important notification for IVDR Class C device manufacturers

Deadline for application is quickly approaching; 26 May 2026.

Supporting Investigator Initiated Clinical Studies—From Start to Finish

Many important clinical studies start with researchers – not pharmaceutical companies. In investigator initiated studies, pharmaceutical companies often support...

Thermo Fisher Expands in Sweden – “We Are Sending a Clear Message”

The American life science giant Thermo Fisher Scientific has inaugurated a new distribution center in Uppsala. “By investing in increasing our capacity as well ...

A food-based strategy to stop gut infections early

Most gastrointestinal infections are treated only after symptoms have already developed. Researcher Andreas Hougaard Laustsen-Kiel aims to reduce risk earlier b...